Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-03-31

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Can a combination of prenatal screening blood tests, early ultrasound, and a 3D ultrasound of the fetal face at approximately 20 weeks gestation identify fetuses with congenital anomalies and predict maternal and fetal complications?

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development of a Prenatal Test for Fetal Aneuploidy Detection

NCT01451671

Fetal Complications

COMPLETED

Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy

NCT02982356

Chromosome Abnormality Twin Pregnancy With Antenatal Problem

UNKNOWN NA

Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

NCT00971334

Pregnancy Aneuploidy Down Syndrome +1 more

COMPLETED

Antenatal Detection by Array CGH Genomic Rearrangements Unbalanced Front Uninsulated Thick Neck or a Combination of Two Signs of Ultrasound Calling Normal Karyotype

NCT03239002

Abnormality of the Neck Fetus; Abnormal, Affecting Management of Pregnancy

COMPLETED

Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

NCT00770458

Down Syndrome (Trisomy 21) Edwards Syndrome (Trisomy 18) Patau Syndrome (Trisomy 13) +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pts will be consented upon presenting to the department for a comprehensive ultrasound.The 3D picture is the only part of the study that is not part of standard obstetrical care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Fetal Aneuploidy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women at approximately 20 weeks
* ages 18-50
* singleton pregnancy
* plans to deliver at North Shore University Hosp
* completed step-wise sequential screening

Exclusion Criteria

* multifetal gestation
* minors
* patients who have undergone diagnostic genetic testing
* incarcerated patients
* intention to deliver at a hospital other than North Shore University hosp

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes